ArticleCureus2024
Corneal Endothelial Graft Failure After Endoscopic Cyclophotocoagulation: A Case Report.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We report a case of corneal endothelial graft failure that developed after endoscopic cyclophotocoagulation (ECP) for elevated intraocular pressure (IOP) following Descemet's stripping automated endothelial keratoplasty (DSAEK). The patient was a 69-year-old Japanese woman with primary angle-closure glaucoma who had undergone phacoemulsification with intraocular lens implantation and goniosynechialysis for peripheral anterior synechiae (PAS), followed by trabeculectomy, repeat bleb revisions, Baerveldt glaucoma implant surgery, and Ahmed glaucoma valve implantation with tube insertion into the anterior chamber in the past two years. Subsequently, she developed bullous keratopathy, and the first DSAEK was performed in July 2020. Subsequently, iris adhesion and atrophy progressed around the tube, and PAS became severe, resulting in graft failure. A second DSAEK combined with pupilloplasty was performed in November 2021, after which the graft transparency was maintained. Since March 2022, IOP has increased despite treatment with maximum medication; therefore, ECP was performed to reduce IOP in September 2022. IOP decreased after ECP; however, the patient developed graft failure within a few months. A third DSAEK was performed in July 2023. In conclusion, for eyes with borderline corneal endothelial cell decompensation, the indications for ECP should be decided with caution.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.